Skip to main content
. 2016 Jan 22;7(8):9041–9045. doi: 10.18632/oncotarget.6984

Table 2. Adverse event and survival ratios with MACH index for drug/comparator pairs.

Drug/Comparator Adverse Events Adverse Event ratio Survival (mo) Survival ratio MACH Index
Bortezomib 0.75 1.25 29.8 1.26 0.99
Dexamethasone 0.60 23.7
Sunitinib 0.37 1.48 26.0 1.30 1.14
Interferon alpha 0.25 20.0
Regorafenib 0.54 3.86 6.40 1.28 3.02
Placebo 0.14 5.00
Sorafenib 0.11 2.06 10.7 1.28 1.62
Placebo 0.05 7.9
Erlotinib 0.65 1.12 12.3 1.11 1.01
Placebo 0.58 11.1